Follow
Sadanand Mallurwar
Sadanand Mallurwar
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Validated HPLC‐MS/MS method for quantitation of AMG 510, a KRAS G12C inhibitor, in mouse plasma and its application to a pharmacokinetic study in mice
N Madhyastha, SK Samantha, S Dittakavi, M Markose, SR Mallurwar, ...
Biomedical Chromatography 35 (4), e5043, 2021
142021
LC–MS/MS-ESI method for simultaneous quantification of darolutamide and its active metabolite, ORM-15341 in mice plasma and its application to a pharmacokinetic study
S Dittakavi, PKVSP Nagasuri, SP Sulochana, SM Saim, SR Mallurwar, ...
Journal of Pharmaceutical and Biomedical Analysis 145, 454-461, 2017
142017
Discovery and characterization of potent pan-genotypic HCV NS5A inhibitors containing novel tricyclic central core leading to clinical candidate
V Ramdas, R Talwar, M Banerjee, AA Joshi, AK Das, DS Walke, ...
Journal of Medicinal Chemistry 62 (23), 10563-10582, 2019
132019
Determination of tofacitinib in mice whole blood on dried blood spots using LC–ESI–MS/MS: application to pharmacokinetic study in mice
A Dixit, SR Mallurwar, SP Sulochana, M Zainuddin, R Mullangi
Drug Research 69 (06), 330-336, 2019
112019
Discovery of a Potent and Selective PI3Kδ Inhibitor (S)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4H-quinolizin-2-yl)ethyl)amino)pyrimidine-5 …
MR Shukla, S Patra, M Verma, G Sadasivam, N Jana, SJ Mahangare, ...
Journal of Medicinal Chemistry 63 (23), 14700-14723, 2020
102020
Discovery of isoquinolinone and naphthyridinone-based inhibitors of poly (ADP-ribose) polymerase-1 (PARP1) as anticancer agents: Structure activity relationship and preclinical …
NP Karche, M Bhonde, N Sinha, G Jana, G Kukreja, SP Kurhade, ...
Bioorganic & Medicinal Chemistry 28 (24), 115819, 2020
92020
Simultaneous determination of bendamustine and γ-hydroxybendamustine in mice dried blood spots and its application in a mice pharmacokinetic study
NK Saini, SP Sulochana, V Kiran, SR Mallurwar, W Richter, NR Srinivas, ...
Journal of Pharmaceutical and Biomedical Analysis 174, 168-174, 2019
72019
Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-N-(2′-methyl-3′-(4-methyl-5-oxo-4,5-dihydro-1,3,4 …
NR Khedkar, NR Irlapatti, D Dadke, V Kanoje, Z Shaikh, V Karche, ...
Journal of Medicinal Chemistry 64 (23), 17004-17030, 2021
62021
Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: Relevance to human ocular injection of cefuroxime
RK Jairam, SR Mallurwar, BB Gabani, A Zakkula, V Kiran, S Dittakavi, ...
Xenobiotica 50 (3), 339-345, 2020
62020
Clinical Prospectives of Janus Kinase Inhibitors: A review
SR Mallurwar, VK Nakra, MR Bhat
Asian J Pharm Pharmacol 7 (2), 85-91, 2021
22021
Validated LC-ESI-MS/MS method for the determination of ivosidenib in 10 µL mice plasma: application to a pharmacokinetic study
S Dittakavi, RK Jat, SR Mallurwar, RK Jairam, R Mullangi
ADMET and DMPK 7 (2), 131-139, 2019
22019
Prediction of human pharmacokinetics of bendamustine from preclinical species pharmacokinetics based on normalizing time course profiles
RK Jairam, SR Mallurwar, SP Sulochana, DV Chandrasekar, ...
Drug Research 69 (01), 32-39, 2019
22019
Advantages of Allometric Scaling Methods for Predicting Human Pharmacokinetics of Novel JAK Inhibitor-Baricitinib and Dose Extrapolation
S Mallurwar, K Daniel, M Bhat
Biomedical and Pharmacology Journal 15 (1), 543-552, 2022
12022
Prediction of Human Pharmacokinetics of Fomepizole from Preclinical Species Pharmacokinetics Based on Normalizing Time Course Profiles
RK Jairam, SR Mallurwar, SP Sulochana, DV Chandrasekhar, U Todmal, ...
AAPS PharmSciTech 20 (6), 221, 2019
12019
MRTX-1257
N Madhyastha, SK Samantha, S Dittakavi, M Markose, SR Mallurwar, ...
Comparative Analysis of Plasma and Dried Plasma Spots (DPS) of Tofacitinib-A Pan JAK inhibitor using LC-MS/MS; Application to Pharmacokinetic Study in Mice
S Mallurwar, R Trivedi, M Bhat, P Jain
The system can't perform the operation now. Try again later.
Articles 1–16